Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma

Pathology International

Volumn 62, Issue 12, 2012, Pages 823-826

  Nakayama, Robert ^a   Miura, Yasuhiro ^a   Ogino, Jiro ^a   Susa, Michiro ^a   Watanabe, Itsuo ^a   Horiuchi, Keisuke ^a   Anazawa, Ukei ^b   Toyama, Yoshiaki ^a   Morioka, Hideo ^a   Mukai, Makio ^a   Hasegawa, Tadashi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Fluorescence in situ hybridization; Fusion gene; Mesenchymal chondrosarcoma

Indexed keywords

HEY1 PROTEIN; HYBRID PROTEIN; NCOA2 PROTEIN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER TISSUE; CHONDROSARCOMA; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ADOLESCENT; ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE NEOPLASMS; CELL CYCLE PROTEINS; CHONDROSARCOMA, MESENCHYMAL; FORMALDEHYDE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEAR RECEPTOR COACTIVATOR 2; ONCOGENE PROTEINS, FUSION; PARAFFIN EMBEDDING; TISSUE FIXATION; YOUNG ADULT;

EID: 84871366771     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12022     Document Type: Article

References (18)

1. Nakashima Y, Park YK, Sugano O. Mesenchymal chondrosarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002; 255-256. World Health Organization Classification of Tumours; vol 4.
2. Huvos AG, Rosen G, Dabska M, Marcove RC. Mesenchymal chondrosarcoma: A clinicopathologic analysis of 35 patients with emphasis on treatment. Cancer 1983; 51: 1230-1237.
3. Nakashima Y, Unni KK, Shives TC, Swee RG, Dahlin DC. Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer 1986; 57: 2444-2453.
4. Dantonello TM, Int-Veen C, Leuschner I etal. Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: Experiences of the CWS and COSS study groups. Cancer 2008; 112: 2424-2431.
5. Dabska M, Huvos AG. Mesenchymal chondrosarcoma in the young. Virchows Arch A Pathol Anat Histopathol 1983; 399: 89-104.
6. Lockhart R, Menard P, Martin JP, Auriol M, Vaillant JM, Bertrand JC. Mesenchymal chondrosarcoma of the jaws. Report of four cases. Int J Oral Maxillofac Surg 1998; 27: 358-362.
7. Vencio EF, Reeve CM, Unni KK, Nascimento AG. Mesenchymal chondrosarcoma of the jaw bones: Clinicopathologic study of 19 cases. Cancer 1998; 82: 2350-2355.
8. Shakked RJ, Geller DS, Gorlick R, Dorfman HD. Mesenchymal chondrosarcoma: Clinicopathologic study of 20 cases. Arch Pathol Lab Med 2012; 136: 61-75.
9. Rushing EJ, Armonda RA, Ansari Q, Mena H. Mesenchymal chondrosarcoma: A clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system. Cancer 1996; 77: 1884-1891.
10. Salvati M, Caroli E, Frati A etal. Central nervous system mesenchymal chondrosarcoma. J Exp Clin Cancer Res 2005; 24: 317-324.
11. Scheithauer BW, Rubinstein LJ. Meningeal mesenchymal chondrosarcoma: Report of 8 cases with review of the literature. Cancer 1978; 42: 2744-2752.
12. Fanburg-Smith JC, Auerbach A, Marwaha JS etal. Immunoprofile of mesenchymal chondrosarcoma: Aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases. Ann Diagn Pathol 2010; 14: 8-14.
13. Granter SR, Renshaw AA, Fletcher CD, Bhan AK, Rosenberg AE. CD99 reactivity in mesenchymal chondrosarcoma. Hum Pathol 1996; 27: 1273-1276.
14. Wehrli BM, Huang W, De Crombrugghe B, Ayala AG, Czerniak B. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol 2003; 34: 263-269.
15. Fanburg-Smith JC, Auerbach A, Marwaha JS, Wang Z, Rushing EJ. Reappraisal of mesenchymal chondrosarcoma: Novel morphologic observations of the hyaline cartilage and endochondral ossification and b-catenin, Sox9, and osteocalcin immunostaining of 22 cases. Hum Pathol 2010; 41: 653-662.
16. Muller S, Soder S, Oliveira AM, Inwards CY, Aigner T. Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton. Mod Pathol 2005; 18: 1088-1094.
17. Wang L, Motoi T, Khanin R etal. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 2012; 51: 127-139.
18. Miura Y, Keira Y, Ogino J etal. Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors. Pathol Int 2012; 62: 16-27.